-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Apellis Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from Q2 2018 to Q2 2024.
- Apellis Pharmaceuticals, Inc. Return On Equity for the quarter ending June 30, 2024 was -139 %, a 34.7% increase year-over-year.
- Apellis Pharmaceuticals, Inc. annual Return On Equity for 2023 was -179 %, a 12.8% increase from 2022.
- Apellis Pharmaceuticals, Inc. annual Return On Equity for 2022 was -205 %, a 96.5% increase from 2021.
- Apellis Pharmaceuticals, Inc. annual Return On Equity for 2021 was -5.8K %, a 3268% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)